Introduction
Chromosomal translocations involving the MLL gene on chromosome band 11q23 are found in de novo acute leukemias. It is the most common genetic aberration in both infant acute lymphoblastic leukemia (ALL) (70-80%) and infant acute myeloid leukemia (AML) (60%), 1,2 while the incidence in childhood and adult ALL and AML is much lower (5-8%). 3, 4 11q23 aberrations are also frequently found in patients with secondary AML after therapy including topoisomerase II inhibitors. 5 The MLL gene, also named ALL-1, Htrx and HRX, is the human homologue of the Drosophila trithorax gene. 6 The human gene consists of 37 exons and spans a region of approximately 100 kb. 7 The MLL protein contains a transcription repression domain, an activation domain and two types of DNA binding domains (minor groove DNA binding 'AThook' motifs and major groove binding zinc fingers). 8 MLL functions as a transcriptional maintenance factor in morphogenesis. 9, 10 Absence of the MLL gene blocks hematopoietic differentiation in vitro and is possibly important in leukemogenesis. 11 Translocations involving MLL disrupt the gene between the two types of DNA binding motifs; the breaks are clustered within a 6.5 kb major breakpoint region (mbr) located on an 8.3 kb BamHI fragment. 6, 12 The 'AT-hook' motifs and the repression domain remain on the der (11) , while the zinc fingers and the activation domain are either lost or translocated to the der(partner) chromosome. 8 In most translocations the fusion protein of the derivative 11 chromosome, with the 5Ј part of the MLL gene fused to the 3Ј part of the partner gene, contributes to the oncogenic process. 13 More than 30 different partner chromosome regions have been identified of which 18 partner genes have been cloned. 14 The t(4;11)(q21;q23) and t(11;19)(q23;p13.3) are the most common translocations in ALL, whereas t(6;11) (q27;q23), t(9;11)(p21-p22;q23), t(10;11)(p12;q23) and t(11;19) (q23;p13.1) are most frequent in AML. [15] [16] [17] [18] [19] [20] Rapid detection of an MLL gene translocation at diagnosis is of high clinical relevance, because the presence of this aberration has direct consequences for treatment stratification due to the fact that MLL gene rearrangements are generally correlated with poor prognosis. 4 Translocations involving 11q23 can be detected by conventional cytogenetics, Southern blotting, RT-PCR and FISH. Each technique has its advantages and disadvantages concerning time, technical complexity, required laboratory facilities and level of experience. Conventional cytogenetics would allow, in principle, detection of all chromosome aberrations; however, metaphases are a prerequisite and a translocation can only be detected and identified if it causes a clear difference in the chromosome banding pattern. Southern blotting enables the detection of all 11q23 rearrangements, but DNA of high quality is required and distinction between duplication and rearrangement of the MLL gene is not possible. Moreover, the partner gene cannot be identified. RT-PCR can only detect MLL gene translocations with well-defined (sequenced) partner genes. FISH is a rapid technique, which has advantages above those previously mentioned.
In this study, we designed a FISH probe set based on the concept that a translocation would result in separation of the fusion signal found under normal circumstances. This involved the selection of two probes flanking the mbr of the MLL gene on chromosome 11. For this purpose, PCR-generated inclusion and exclusion probes were used in order to screen a chromosome 11 specific cosmid library. The carefully selected FISH probes could be used both in interphase and in metaphase FISH. The advantage of this probe design strategy is that all types of MLL gene translocations can be detected in a sensitive way in a single FISH test, without the necessity for metaphases. Furthermore, this strategy avoids high levels of false-positivity, as is frequently seen with FISH probes, which give separate signals in case of normal cells and a fusion signal in case of the chromosome aberration.
Materials and methods

Patient samples and cell line
For the present study, cytogenetic preparations of four ALL and six AML patients were selected based on the presence of an 11q23 translocation, together with five ALL and five AML patients with either a normal karyotype or no 11q23 aberration. Cytogenetic analysis at diagnosis was carried out on freshly obtained bone marrow or peripheral blood cells, which were cultured and harvested according to routine cytogenetic procedures. Chromosomes were described according to the convention of the International System for Human Cytogenetic Nomenclature (ISCN 95). To further characterize the samples, Southern blot analysis was performed to detect MLL gene rearrangements as described by Hernandez et al. 21 RT-PCR was done in a limited number of cases to confirm the presence of a particular MLL gene translocation. 22, 23 The precursor-B cell line RS4;11 characterized by t(4;11) was used as positive control for interphase and metaphase FISH. 24 
Inclusion and exclusion probes
Five primer sets were developed in exons 4, 8, 17, 28, and 37 of the MLL gene using the OLIGO 6.2 software program (Dr W Rychlik, Molecular Biology Insights Inc, Cascade, CO, USA). DNA of a healthy individual was used to generate the PCR products of these exons. The PCR conditions were: 10 min at 94°C to activate the AmpliTaq Gold™ polymerase (PE Biosystems, Foster City, CA, USA) followed by 1 min at 94°C, 1 min at 60°C, and 2 min at 72°C for 35 cycles. The PCR products were analyzed on a 1% agarose gel. The PCR products from exon 4 (MLL4) and exon 37 (MLL37) were used as screening probes for the chromosome 11 specific cosmid library and probes of exon 8, exon 17 and exon 28 (MLL8, MLL17 and MLL28) were used for further selection.
Library screening and cosmid isolation
Chromosome 11 specific cosmid library 107:L4/FS11 (Resourcezentrum im Deutschen Humangenomprojekt RZPD, Berlin, Germany) was hybridized with the 32 P-dATP and 32 PdCTP labeled MLL4 and MLL37 inclusion probes. Bacterial colonies with positive cosmids were ordered and cultured according to the manufacturer's instructions. The cosmid DNA was isolated using an alkaline lysis protocol. 25 
Fluorescent in situ hybridization (FISH)
Dual colored FISH was carried out with FISH probes, which were labeled by nick-translation with either biotin-16-dUTP or digoxigenin-11-dUTP (Boehringer Mannheim, Mannheim, Germany). For FISH analysis, leukemic metaphase preparations stored at −20°C for up to several years or freshly prepared preparations from −20°C stored methanol/acetic acid fixed cell suspensions were used. FISH was carried out according to standard procedures. 26 Briefly, slides were pretreated with RNAse and pepsin, and subsequently fixed with formaldehyde. Hybridization of 100 ng of each probe to the slides was performed overnight at 37°C. Biotinylated probes were detected via subsequent incubation with FITC-labeled avidin d, biotinylated goat-anti-avidin and avidin d-FITC (Vector, Burlingame, CA, USA), whereas digoxigenin-labeled probes were detected via sheep anti-digoxigenin TRITClabeled antibodies (Boehringer Mannheim), followed by Texas-red-conjugated donkey-anti-sheep antibodies (Jackson ImmunoResearch, West Grove, PA, USA).
The slides were counterstained with DAPI and embedded in Vectashield/DABCO. Per sample a minimum of 200-300 interphase cells was blindly scored by either of two independent observers, as well as 5-10 metaphase cells whenever possible.
Results
Design of inclusion and exclusion probes
To select FISH probes that were positioned around the MLL mbr without overlapping the region, inclusion and exclusion regions were defined. As the FISH probes needed to be positive for either exon 4 or exon 37, two PCR-based inclusion probes were designed in these regions: MLL4 and MLL37 (Figure 1a ). To exclude FISH probes that overlap with the breakpoint region, which could give rise to additional signals, two probes (MLL8 and MLL16) were designed in the exons juxtaposed to the breakpoint region. Probe MLL28 was used for further positioning of FISH probes in the downstream MLL region.
Library screening
The chromosome 11 specific cosmid library was screened with the inclusion probes to select the cosmids that could potentially be used as FISH probes. One positive colony was found with MLL4 and six with MLL37. Positivity of the cosmid clones was confirmed by PCR analysis (Figure 1b ). All cosmids were negative for the exclusion probes MLL8 and MLL16, and therefore not overlapping with the breakpoint region. The cosmid, which was positive for MLL4 was used as upstream FISH probe (MLL-U). Although the six MLL37 positive cosmids were largely overlapping, as determined by PCR and restriction fragment analysis, only one of them was positive for MLL28 (Figure 1b) . 
Testing of FISH probes
The selected MLL upstream FISH probe (MLL-U) was tested in combination with the six MLL downstream probes in interphase FISH on slides of PHA-stimulated peripheral blood mononuclear cells of a healthy donor, on cell line RS4;11, and on one ALL and one AML sample without 11q23 translocation. As downstream MLL FISH probe (MLL-D) the cosmid was selected, which gave the best colocalized (fused) signal in combination with MLL-U (Figure 2a) . This was the cosmid positive for MLL28 (Figure 1b) . When tested on the RS4;11 cell line, the presence of the MLL translocation resulted in the splitting of one of the two colocalizing signals, giving rise to separate green and red signals (Figure 2b ). In metaphases, MLL-U remained on the der(11), whilst MLL-D moved to the der(4). Hybridization of MLL-U and MLL-D to metaphase spreads of AML patient without an 11q23 aberration clearly shows the positioning of the probes on chromosome 11 ( Figure 2c ).
Detection of MLL translocations and deletions
A series of 10 ALL and AML samples with different 11q23 aberrations was selected (patients 1 to 10, Table 1 ). By conventional karyotyping seven different MLL translocations had been identified, involving six partner chromosomes (4, 6, 9, 10, 18, and 19). The presence of an MLL gene rearrangement was confirmed by Southern blotting in nine patients (2 to 10) and specific MLL translocations were demonstrated by RT-PCR in five patients (1 to 5).
In patients 1 to 7 a fused red/green signal, and separate red and green signals were observed in 90.4-97.7% of the interphase nuclei, demonstrating the presence of an MLL translocation ( Table 1 ). The partner chromosome could be identified in those cases where metaphase spreads were present on the slide. Figure 2d and e show two metaphase spreads of patients 1 and 4 with t(9;11)(p21-22;q23) and t(6;11)(q27;q23), respectively. In both cases the MLL-D probe is located on the derivative partner chromosome: der(9) and der(6).
In patients 8 to 10 one fusion signal and one separate signal of the MLL-U probe were observed in 88.3-97.1% of the nuclei, whereas the signal of MLL-D was lost. Interphase nuclei of patient 8 are shown in Figure 2f . Loss of the MLL-D signal implies a deletion of the region telomeric from the breakpoint region with a minimum size of 40 kb, ie the size of the cosmid. Deletion of the 3Ј end of the MLL gene was observed in three different translocations: ins(10;11), t(6;11) and t(9;11). These translocations were also present in our ser- -22;q23) . The red MLL-U probe hybridized to der (11) and MLL-D (green) to der (9) . A colocalized signal is visible on the normal chromosome 11. (e) Metaphase spread of AML-M4 patient 4 with t(6;11)(q27;q23). The MLL-D probe moved to der(6) while MLL-U is located on der (11) . (f and g) Interphase and metaphase cells of AML-M5 patient 8 with ins(10;11)(p12;q23q13). The colocalized signal and one red signal are visible, while the green signal is lost demonstrating the deletion of the 3Ј part of the MLL gene. Since the inserted region of chromosome 11(q23q13) into the short arm of chromosome 10 also includes the 5Ј end of the MLL gene, MLL-U is located on der(10). ies without a deletion. Figure 2g shows a metaphase spread of patient 8 with ins(10;11). The colocalizing (fused) signal is located on the normal chromosome 11 homologue. Since the inserted region of chromosome 11(q23q13) on the short arm of chromosome 10 also includes the 5Ј end of the MLL gene, the red signal of the MLL-U probe is located on the der(10). This type of translocation has been previously described by Beverloo et al. 26 The green signal (MLL-D) was lost in this patient indicating the deletion of the 3Ј part of the MLL gene.
Determining cut-off values
To validate the MLL FISH probe set, the cut off value was determined. For this purpose ALL and AML samples were selected which did not have 11q23 aberrations based on karyotyping and Southern blotting in order to evaluate the performance of this MLL FISH probe set in a diagnostic setting. Two independent observers counted in total 500-800 cells per sample. The results are summarized in Table 1 (patients  11-20) .
Although we did not expect to find split signals in the AML and ALL samples without 11q23 aberration, a few (false) positive cells were detected, eg 1/700 (0.1%) in patient 12 and 8/500 (1.6%) in patient 19 ( Table 1 ). The cut off value for the translocation (RG/R/G, Table 1 ), defined as the mean value of the 10 leukemia samples without 11q23 aberration plus three times the standard deviation, was 1.7%. The cut off value for the translocations with MLL 3Ј end deletions (RG/R or G) was 1.8%. All the percentages of the patterns RG/R/G and RG/R or G in the leukemia samples without 11q23 translocation appeared to be lower than the cut off value.
We also evaluated the FISH probe set on material of seven AML/ALL patients in complete remission (Ͻ2% blasts). The cut off values were 1.0% for the translocation and 1.6% for the 3Ј deletion, respectively (data not shown). This did not differ from the values observed in material from patients at diagnosis.
Discussion
Traditionally, in dual colored FISH experiments the presence of a translocation is detected by the formation of a fusion signal. 27 The inherent disadvantage of this approach of probe selection is the rather high risk of false-positive results, due to coincidental colocalization, which results in background levels of at least 5 to 10%. This makes the classical FISH probe design unsuitable for detection of low frequencies of malignant cells. Moreover, both partner genes need to be known to select FISH probes for the detection of the translocation, which is difficult since the MLL gene is involved in more than 30 different translocations.
We developed a different approach for FISH probe design to circumvent these disadvantages. Our method is based on the split-signal FISH concept, which means that two colocalized (fusion) signals are present on normal chromosomes and that the presence of an MLL gene translocation results in a split of one of the fused signals, ie giving rise to separate red and green signals. For this purpose FISH probes were selected, which flanked both sides of the MLL breakpoint region without overlap. This approach has two major advantages: it prevents the traditional high levels of false-positivity and it allows the detection of all types of MLL gene translocations, independent of the partner gene. Split-signal FISH can give rise to low frequencies of false-negativity due to coincidental colocalization of signals; these cells are not distinguishable from normal nuclei. However, 5-10% false-negativity (as expected from conventional FISH) within the leukemic cell population will not alter the result in diagnostic material where the blast percentage is over 30%.
We have shown that the selected FISH probe set allows the detection of 11q23 translocations by interphase FISH, independent of the partner chromosome, with a cut off value of only 1.7%. In our series of 10 patients with different 11q23 translocations, three patients had a deletion of at least 40 kb of the region telomeric from the MLL breakpoint region. This phenomenon has also been observed by other investigators and the incidence was estimated to be 25-30%. [28] [29] [30] The occurrence of 3Ј deletions of the MLL gene supports the molecular observations that the fusion of the 5Ј part of the MLL gene carries the critical part for leukemogenesis. 13 MLL rearrangements are generally correlated with a poor prognosis, especially in infants. However, several studies showed that adult primary AML and childhood AML patients with t(9;11)(p21-p22;q23) have a significantly better clinical outcome than patients with other translocations involving 11q23. 31, 32 For this reason simultaneous identification of the partner chromosome is needed for predicting clinical behavior in patients with MLL translocations. 33 With this split-signal probe set, the partner chromosome can be identified in the leukemic metaphase spreads present on the slide. As a result of the translocation, the one probe (MLL-D) moves to the partner chromosome of chromosome 11, ie der(partner), while the other (MLL-U) probe remains on the der(11) chromosome. However, in cases with a deletion of the 3Ј part of the MLL gene, the MLL-D probe cannot be used for partner chromosome identification, unless the 5Ј part of the MLL gene translocated to the partner chromosome, as was observed in the rare case with ins(10;11). 26 Several techniques such as (multiplex) RT-PCR analysis and a RACE based PCR have been described for the identification of translocations involving known partner genes, 34, 35 whilst Felix et al 36, 37 have applied pan-handle PCR analysis for the identification of unknown partner genes.
Our split-signal FISH methodology will facilitate the identification of known and new translocations involving MLL. Together with the application of molecular techniques such as pan-handle PCR analysis, this may lead to the identification of new partner genes.
